Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Capture the Fracture Partnership aims to prevent 250 million fractures by 2025 and combat the global public health burden of osteoporosis.

The University of Oxford has joined a collaboration with the International Osteoporosis Foundation (IOF), in support of its Capture the Fracture programme. Together with Amgen, and UCB, their goal is to reduce hip and vertebral fractures by 25% by 2025.

The team from NDORMS; Professor Cyrus Cooper, Dr. Kassim Javaid, and Dr. Rafael Pinedo-Villanueva, bring their collective experience to address the challenge of an estimated 200 million people worldwide suffering from osteoporosis, resulting in an osteoporosis-related fracture every three seconds.

Osteoporosis is a serious chronic condition that weakens bones over time, making them thinner and more likely to break, but there are steps patients and healthcare providers can take to reduce fracture risk. Capture the Fracture is a global programme that helps to proactively implement post-fracture care (PFC) coordination programs in hospitals and healthcare systems to help patients prevent subsequent fractures due to osteoporosis. Even after an osteoporosis-related fracture approximately 80% of individuals at high risk are still not identified or treated.

"We are currently witnessing a significant disease burden. As the worldwide aging population steadily increases, it has never been more important to address the impact that osteoporosis and associated fractures can have on individuals," said professor Cyrus Cooper, President of the International Osteoporosis Foundation and Professor of Musculoskeletal Science at NDORMS, Oxford.

"Osteoporosis remains a global concern, resulting in 8.9 million fractures in a single year and a previous fracture increases the risk of another osteoporosis-related fracture by 86%. Early intervention through improved post-fracture identification, diagnosis and treatment in appropriate patients can help improve outcomes while also lessening the cost burden on healthcare systems," said Darryl Sleep, M.D., senior vice president of Global Medical and chief medical officer at Amgen.

"Capture the Fracture is an incredible opportunity to take the academic skills and expertise from the University to deliver real improvements in patient care for osteoporosis," said Dr. Kassim Javaid, associate professor at NDORMS, who has led one of the largest Fracture Liaison Services (FLS) providing post-fracture care in Oxford over the last 10 years. Established to identify patients with 'fragility fractures', FLS' provide osteoporosis treatments and services to improve bone health and reduce the risk of further fractures.

Dr. Javaid, along with Dr. Rafael Pinedo-Villanueva, will be responsible for a mentorship program to teach other health providers globally to run PFCs. They are also developing a care pathway and benefits calculator tool for the PFC program. "We hope that through this program millions of lives will be changed and we look forward to working with national and international colleagues to deliver this vision," Dr Javaid commented.

The partnership aims to double the 390 existing Capture the Fracture programs by the end of 2022, and will focus on key regions including Asia Pacific, Latin America, the Middle East, and Europe.

"We know post-fracture coordinated care implementation is the most effective and efficient intervention to close the secondary fracture prevention gap, so I'm delighted that Amgen, UCB and the University of Oxford will support our Capture the Fracture program as we embark on a mission to improve outcomes for patients," said IOF chief executive officer, Dr. Philippe Halbout.

Similar stories

New children’s orthopaedic hospital opens in Zimbabwe

Main

A new children’s orthopaedic hospital in Bulawayo that will treat children across Zimbabwe who are living with musculoskeletal impairments has opened today.

Professor Katja Simon elected to the Academy of Medical Sciences

Awards Kennedy Main

Professor of Immunology Katja Simon has been elected as a Fellow of the Academy of Medical Sciences.

3,400 different medicines used globally to treat COVID-19

Main Statistics and epidemiology

Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.